Surgery Partners Inc (SGRY) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... [Yahoo! Finance]
Surgery Partners, Inc. (SGRY)
Last surgery partners, inc. earnings: 3/5 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.surgerypartners.com/investor-overview
Company Research
Source: Yahoo! Finance
Adjusted EBITDA: $136.4 million, up 6.1% year-over-year. Adjusted EBITDA Margin: Same Facility Revenue Growth: Surgical Cases: Over 166,000 performed in the third quarter, representing 2.1% growth. Cash Balance: $203.4 million. Total Available Liquidity: Over $600 million. Operating Cash Flow: $83.6 million for the third quarter. Capital Deployment for Acquisitions: Approximately $71 million in 2025. Debt: Approximately $2.2 billion in outstanding corporate debt with no maturities until 2030. Net Leverage Ratio: 4.2 times under the credit agreement, 4.6 times on a balance sheet net debt-to-EBITDA basis. Revised Full Year Revenue Guidance: $3.275 billion to $3.3 billion. Revised Full Year Adjusted EBITDA Guidance: $535 million to $540 million. Same Facility Revenue Growth Guidance: Closer to the midpoint of 4% to 6% for the full year. Warning! GuruFocus has detected 5 Warning Signs with SGRY. Is SGRY fairly valued? Test your thesis with our free DCF calcula
Show less
Read more
Impact Snapshot
Event Time:
SGRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SGRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SGRY alerts
High impacting Surgery Partners, Inc. news events
Weekly update
A roundup of the hottest topics
SGRY
News
- Surgery Partners (NASDAQ:SGRY) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Assessing Surgery Partners (SGRY) Valuation Following Fed-Driven Investor Optimism and Recent Share Price Rebound [Yahoo! Finance]Yahoo! Finance
- Surgery Partners (NASDAQ:SGRY) had its price target lowered by analysts at JPMorgan Chase & Co. from $27.00 to $20.00. They now have a "neutral" rating on the stock.MarketBeat
- Surgery Partners (NASDAQ:SGRY) was given a new $18.00 price target on by analysts at Barclays PLC.MarketBeat
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surgery Partners, Inc. - SGRYPR Newswire
SGRY
Earnings
- 11/10/25 - Beat
SGRY
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/14/25 - Form SCHEDULE
- 11/14/25 - Form SCHEDULE
- SGRY's page on the SEC website